• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

CLIA - Clinical Laboratory Improvement Amendments

  • Print
  • Share
  • E-mail
-
1 to 7 of 7 Results
Document Number K083764
Results per Page

New Searchexport reports to excelExport to Excel | HelpHelp
Document Parent Analyte Analyte Specialty Complexity Effective Date
Roche Diagnostics, cobas pro integrated solutions, cobas c 703  {ONLINE DAT Amphetamines II} 
CR260281 K083764 Amphetamines Toxicology / TDM MODERATE 04/28/2026
Roche Diagnostics, cobas c 303  {ONLINE DAT Amphetamines II} 
CR220440 k083764 Amphetamines Toxicology / TDM MODERATE 12/05/2022
Roche Diagnostics cobas c 503 analytical unit  
CR200029 K083764 Amphetamines Toxicology / TDM MODERATE 02/19/2020
Roche Diagnostics cobas c 502 Analyzer  
K100853 K083764 Amphetamines Toxicology / TDM MODERATE 01/10/2011
Olympus AU 5400  {Roche Diagnostics Amphetamines II assay} 
K083764 K083764 Amphetamines Toxicology / TDM MODERATE 06/18/2010
Roche Diagnostics Cobas c 311  
K083764 K083764 Amphetamines Toxicology / TDM MODERATE 04/15/2010
Roche Diagnostics Hitachi Modular Analytics P System  
K083764 K083764 Amphetamines Toxicology / TDM MODERATE 04/15/2010

-
-